Novare Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $210K | Sell |
|
|||||
|
2025
Q2 | $250K | Sell |
|
|||||
|
2025
Q1 | $381K | Hold |
|
|||||
|
2024
Q4 | $354K | Buy |
|
|||||
|
2024
Q3 | $255K | Buy |
|
|||||
|
2024
Q2 | $200K | Sell |
|
|||||
|
2024
Q1 | $316K | Buy |
|
|||||
|
2023
Q4 | $204K | Sell |
|
|||||
|
2023
Q3 | $260K | Sell |
|
|||||
|
2023
Q2 | $299K | Buy |
|
|||||
|
2023
Q1 | $320K | Sell |
|
|||||
|
2022
Q4 | $439K | Sell |
|
|||||
|
2022
Q3 | $807K | Sell |
|
|||||
|
2022
Q2 | $906K | Sell |
|
|||||
|
2022
Q1 | $8.29M | Sell |
|
|||||
|
2021
Q4 | $7.08M | Sell |
|
|||||
|
2021
Q3 | $6.81M | Buy |
|
|||||
|
2021
Q2 | $7.62M | Buy |
|
|||||
|
2021
Q1 | $6.98M | Buy |
|
|||||
|
2020
Q4 | $6.75M | Sell |
|
|||||
|
2020
Q3 | $6.64M | Sell |
|
|||||
|
2020
Q2 | $6.53M | Sell |
|
|||||
|
2020
Q1 | $6.21M | Buy |
|
|||||
|
2019
Q4 | $6.54M | Buy |
|
|||||
|
2019
Q3 | $4.91M | Buy |
|
|||||
|
2019
Q2 | $3.41M | Buy |
|
|||||
|
2019
Q1 | $3.06M | Buy |
|
|||||
|
2018
Q4 | $2.82M | Sell |
|
|||||
|
2018
Q3 | $3.04M | Hold |
|
|||||
|
2018
Q2 | $3M | Buy |
|
|||||
|
2018
Q1 | $2.68M | Buy |
|
|||||
|
2017
Q4 | $2.34M | Sell |
|
|||||
|
2017
Q3 | $2.54M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $322K | Sell |
|
|||||
|
2015
Q3 | $285K | Buy |
|